青少年母亲子女的疫苗接种覆盖率与及时性:南非东开普省一项基于社区的研究
本研究在南非东开普省通过医疗与社区采样招募1015名青少年母亲及其1080名子女,从1013份2017—2019年家庭儿童健康记录中提取接种数据,估计DTP3、1岁内疫苗和MCV2覆盖率及及时性。结果显示DTP3覆盖率为85.6%,1岁内疫苗覆盖率为53.2%,MCV2覆盖率为62.3%,且HIV暴露儿童覆盖均低于未暴露儿童;及时性从出生时98.0%降至18月龄时37.3%。
要点
- 青少年母亲子女DTP3覆盖率为85.6%,1岁内疫苗覆盖率为53.2%,MCV2覆盖率为62.3%。
- HIV暴露儿童DTP3、1岁内疫苗和MCV2覆盖均低于未暴露儿童(P值分别为0.01、0.02、0.02)。
- 接种及时性随年龄下降,从出生时98.0%降至18月龄时37.3%。
核心结论
- 南非东开普省青少年母亲的子女疫苗接种覆盖率低于国家目标。
- HIV暴露儿童接种覆盖率低于HIV未暴露儿童。
- 作者指出需进一步研究以识别该群体(尤其HIV暴露儿童)不完整和延迟接种的风险因素。
- 作者提出可能需要针对青少年母亲的子女加强疫苗接种活动。
研究设计与样本
- 研究为基于社区的横断面调查,纳入南非东开普省1015名青少年母亲及其1080名子女。
- 通过医疗保健和社区采样策略招募母子对,从1013份2017—2019年家庭儿童健康记录中提取接种数据。
- 覆盖率用比例及95%置信区间(95%CI)报告,及时性定义为在推荐年龄4周内接种每剂疫苗。
- 结果按母亲HIV状态分层分析。
主要发现
- 27.3%的青少年母亲为HIV感染者。
- DTP3覆盖率为85.6%(95%CI:82.6-88.3%),1岁内疫苗覆盖率为53.2%(95%CI:49.1-57.2%),MCV2覆盖率为62.3%(95%CI:57.2-67.2%)。
- HIV暴露儿童DTP3覆盖率为80.3%,HIV未暴露儿童为88.2%(P=0.01)。
- HIV暴露儿童1岁内疫苗覆盖率为46.5%,HIV未暴露儿童为56.4%(P=0.02);HIV暴露儿童MCV2覆盖率为55.4%,HIV未暴露儿童为67.1%(P=0.02)。
- 接种及时性随时间下降:出生时98.0%,14周时70.7%,9月龄时71.9%,18月龄时37.3%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Children born to adolescent mothers are more vulnerable to infant mortality and morbidity than those born to adult mothers. HIV-exposed children have lower antibody protection against vaccine-preventable diseases at birth compared to unexposed children. In South Africa, 17 % of adolescent girls aged 15-19 years are mothers, yet vaccination coverage and timeliness among their children is underreported. METHODS: This study estimated age-appropriate vaccination coverage and timeliness among children (n = 1080) of adolescent mothers (n = 1015) in the Eastern Cape, South Africa. Mother-child dyads were recruited through healthcare and community-based sampling strategies. Vaccination data were abstracted from 1013 home-based child health records (2017-2019). Coverage is reported for Diphtheria-Tetanus-Pertussis 3rd dose (DTP3), under-1 vaccination among children over 12 months (n = 613) and measles 2nd dose (MCV2) among children over 24 months (n = 382) using proportions with 95 % confidence intervals (95 %CI). Timeliness is defined as receiving each vaccination within 4 weeks of recommended age. Findings are disaggregated by maternal HIV-status. RESULTS: Overall, 27.3 % of adolescent mothers were living with HIV. Coverage of DTP3 was 85.6 % (95 %CI: 82.6-88.3 %), under-1 coverage was 53.2 % (95 %CI: 49.1-57.2 %), and MCV2 coverage was 62.3 % (95 %CI: 57.2-67.2 %). Vaccination coverage was lower among children of adolescent mothers living with HIV (AMLHIV) than unexposed children (DTP3 80.3 % vs 88.2 % p-value: 0.01; under-1 46.5 % vs 56.4 % p-value: 0.02; MCV2 55.4 % vs 67.1 % p-value: 0.02). Timeliness of vaccinations declined over time from 98.0 % at birth, 70.7 % at 14 weeks, 71.9 % at 9 months and 37.3 % at 18 months. CONCLUSION: Vaccination coverage among children of adolescent mothers in the Eastern Cape are below national targets. Children of AMLHIV had lower coverage than HIV-unexposed children. Further research is needed to identify risk factors associated with incomplete and delayed vaccinations among this group, particularly among HIV-exposed children. Enhanced vaccination campaigns may be required for children of adolescent mothers.
引用
- Wittesaele C, Toska E, Cluver L, et al. Vaccine coverage and timeliness among children of adolescent mothers: A community-based study in the Eastern Cape, South Africa. Vaccine. 2024. PMID: 39293297. doi:10.1016/j.vaccine.2024.126318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。